Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001510369 | SCV001717385 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001510369 | SCV001838420 | benign | not provided | 2020-09-02 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26795916) |
Ce |
RCV001510369 | SCV004160701 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | CRB2: PP2, BS1, BS2 |
Breakthrough Genomics, |
RCV001510369 | SCV005320495 | benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001510369 | SCV001800238 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001703101 | SCV001928144 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004550279 | SCV004797717 | benign | CRB2-related disorder | 2021-01-11 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |